Evolving a Pre-Targeting Platform Towards Clinical Translation: Lessons Learned from Candidate Selection & Preclinical Development

• Sharing how OncoOne’s pre-targeting platform has evolved since initial proof-of-concept studies and the key learnings gained through continued development
• Exploring the scientific and technical considerations used to identify and prioritise lead candidates for future clinical advancement
• Analysing preclinical data supporting candidate selection and evaluating the attributes required to achieve a differentiated therapeutic profile

Speakers: